Recently, Li et al., in 2018, screened 4536 Australian women who had a previous negative result from BRCA1 and BRCA2 mutation testing and a family history of breast cancer and a personal history of breast cancer (>95%) or ovarian cancer. The gene discussed is BRCA2; the disease is breast carcinoma.